The Efficacy of the Administration of Fibrinogen in Liver Transplantation
Status:
Unknown status
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Objective:
- To evaluate the efficacy of preoperative administration of fibrinogen in liver
transplantation by maintaining a preoperative plasma level equal to 2.9 g / L compared
with placebo, reflecting a reduction in the number of RBC units transfused during the
procedure.
- To determine the influence of fibrinogen administration on mortality and survival of
liver graft evaluated one year after the procedure.
- To determine the safety of fibrinogen administration recording thrombotic complications
evaluated during hospitalization or at least 30 days postoperatively.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborators:
Spanish Clinical Research Network - CAIBER Spanish Clinical Research Network - SCReN